Dyne Therapeutics DYN
Ownership & positioning
Who holds it, who is betting against it, and where the big money is moving
Short-sale volume as % of daily volume
Large-order net flow, last 20 sessions
Net of large-order buying minus selling, in USD. Over this window: −$12.75M (7 inflow days, 13 outflow days).
Net flow by order size, last 20 sessions
Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.
The five largest holders on file together own 43.0% of shares outstanding.
Largest holders
By investor type
Reported short interest has risen from 11.49% to 13.05% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).
Recent institutional activity
| Holder | Type | Period | Share change | New stake |
|---|---|---|---|---|
| BlackRock | Mutual Fund | 2026/Q3 | +2,067,232 | 7.7% |
| Vanguard Capital Management, LLC | Mutual Fund | 2026/Q3 | +1,241,344 | 4.0% |
| State Street Global Advisors | Mutual Fund | 2026/Q3 | +700,047 | 4.4% |
| Geode Capital Management, LLC | Mutual Fund | 2026/Q3 | +652,945 | 2.3% |
| Fiera Capital Corporation | Mutual Fund | 2026/Q3 | +645,496 | 0.8% |
| Vanguard Portfolio Management, LLC | Mutual Fund | 2026/Q3 | +643,239 | 2.5% |
| Morgan Stanley | Public Company | 2026/Q3 | +424,485 | 0.6% |
| BNY Mellon Asset Management | Mutual Fund | 2026/Q3 | +365,860 | 0.4% |
| Hartford Funds Management Company, LLC | Mutual Fund | 2026/Q3 | +332,751 | 0.2% |
| Artal Group S.A. | VC/PE Fund | 2026/Q3 | +300,000 | 1.3% |
| Hartford Funds Management Company, LLC | Mutual Fund | 2026/Q3 | +311,663 | 0.2% |
| Hartford Funds Management Company, LLC | Mutual Fund | 2026/Q3 | +250,000 | 0.1% |
| FMR | Mutual Fund | 2026/Q3 | +2,298,020 | 6.0% |
| T. Rowe Price Group, Inc. | Mutual Fund | 2026/Q3 | +1,734,919 | 18.6% |
| Marshall Wace LLP | Hedge Fund | 2026/Q3 | +1,405,770 | 0.8% |
Institutional buy/sell activity by reporting period, largest moves first.
Insider transactions
| Date | Insider | Title | Transaction | Shares | Price | Held after |
|---|---|---|---|---|---|---|
| 12 Nov 2026 | Douglas Kerr | Head of Research & Development and Chief Medical Officer | Intent to Sell (Form 144) | -2,604 | $16.82 | – |
| 12 Nov 2026 | John Cox | Chief Executive Officer | Intent to Sell (Form 144) | -5,513 | $16.82 | – |
| 19 Oct 2026 | Douglas Kerr | Head of Research & Development and Chief Medical Officer | Other Acquisition | +8,000 | – | 133,126 |
| 19 Oct 2026 | Douglas Kerr | Head of Research & Development and Chief Medical Officer | Other Derivative Acquisition | +12,000 | $16.27 | 12,000 |
| 1 Oct 2026 | Brian Posner | Independent Director | Open Market Acquisition | +2,500 | $16.00 | 27,000 |
| 7 Sep 2026 | Douglas Kerr | Head of Research & Development and Chief Medical Officer | Intent to Sell (Form 144) | -35 | $18.89 | – |
| 7 Sep 2026 | John Cox | Chief Executive Officer | Automatic Disposition | -5,658 | $18.88 | 190,274 |
| 7 Sep 2026 | Douglas Kerr | Head of Research & Development and Chief Medical Officer | Automatic Disposition | -5,035 | $24.35 | 37,438 |
| 7 Sep 2026 | Johanna Friedl-Naderer | Chief Commercial Officer | Automatic Disposition | -1,085 | $24.35 | 49,931 |
| 3 Sep 2026 | Douglas Kerr | Head of Research & Development and Chief Medical Officer | Intent to Sell (Form 144) | -5,000 | $24.35 | – |
| 13 Aug 2026 | Atlas Venture Advisors, Inc. | Automatic Disposition | -2,586,928 | $26.20 | 3,440,720 | |
| 12 Aug 2026 | Douglas Kerr | Head of Research & Development and Chief Medical Officer | Automatic Disposition | -1,556 | $26.28 | 27,598 |
| 12 Aug 2026 | John Cox | Chief Executive Officer | Automatic Disposition | -4,986 | $26.28 | 186,851 |
| 12 Aug 2026 | Erick Lucera | CFO, Principal Financial Officer & Principal Accounting Officer and Treasurer | Automatic Disposition | -1,797 | $26.28 | 13,315 |
| 12 Aug 2026 | Johanna Friedl-Naderer | Chief Commercial Officer | Automatic Disposition | -226 | $26.28 | 34,054 |
| 26 Jul 2026 | Forbion Capital Partners B.V. | Automatic Disposition | -261,460 | $26.04 | 3,586,796 | |
| 6 Jul 2026 | Atlas Venture Advisors, Inc. | Open Market Disposition | -5,000 | $23.61 | 6,027,648 | |
| 6 Jul 2026 | Atlas Venture Advisors, Inc. | Automatic Disposition | -772,451 | $23.62 | 6,027,648 | |
| 28 Jun 2026 | Atlas Venture Advisors, Inc. | Automatic Disposition | -504,695 | $21.28 | 6,805,099 | |
| 24 Jun 2026 | Erick Lucera | CFO, Principal Financial Officer & Principal Accounting Officer and Treasurer | Open Market Disposition | -2,362 | $20.37 | 11,050 |
From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.
Short interest, by report
| Report date | Shares short | % of float | Days to cover |
|---|---|---|---|
| 30 Oct 2026 | 24,376,615 | 13.1% | 10.8 |
| 15 Oct 2026 | 25,465,761 | 13.6% | 7.4 |
| 30 Sep 2026 | 25,977,390 | 13.9% | 9.0 |
| 15 Sep 2026 | 23,381,047 | 12.5% | 5.5 |
| 31 Aug 2026 | 20,790,669 | 11.1% | 13.5 |
| 14 Aug 2026 | 21,459,799 | 11.5% | 11.0 |
No comments yet — be the first to weigh in on DYN.
Sign in to join the discussion.